White matter hyperintensities are associated with the severity of late-life somatoform disorders and executive functions

References

• Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics 2011;52:263–71.
   PubMed Web of Science ®Google Scholar
• Kisely S, Goldberg D, Simon G. A comparison between somatic symptoms with and without clear organic cause: Results of an international study. Psychol Med 1997;27:1011–19.
   PubMed Web of Science ®Google Scholar
• Lindesay J. Prospects for the classification of mental disorders of the elderly. Eur Psychiatry 2008;23:477–80.
   Google Scholar
• Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005;30:996–1002.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition, text revision): DSM-IV-TR. Washington, DC: American Psychiatric Press; 2000.
   Google Scholar
• van Wilgen CP, van Ittersum MW, Kaptein AA, van Wijhe M. Illness perceptions in patients with fibromyalgia and their relationship to quality of life and catastrophizing. Arthritis Rheum 2008;58:3618–26.
   PubMed Web of Science ®Google Scholar
• Körber S, Frieser D, Steinbrecher N, Hiller W. Classification characteristics of the Patient Health Questionnaire-15 for screening somatoform disorders in a primary care setting. J Psychosom Res 2011;71:142–7.
   PubMed Web of Science ®Google Scholar
• Smith RC, Gardiner JC, Lyles JS, Sirbu C, Dwamena FC, Hodges A, et al. Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med 2005;67:123–9.
   PubMed Web of Science ®Google Scholar
• Pompili M, Serafini G, Innamorati M, Serra G, Forte A, Lester D, et al. White matter hyperintensities, suicide risk and late-onset affective disorders: An overview of the current literature. Clin Ter 2010;161:555–63.
   Google Scholar
• Charlton RA, Lamar M, Zhang A, Yang S, Ajilore O, Kumar A. White-matter tract integrity in late-life depression: Associations with severity and cognition. Psychol Med 2014;44:1427–37.
   Google Scholar
• de Diego-Adeliño J, Pires P, Gómez-Ansón B, Serra-Blasco M, Vives-Gilabert Y, Puigdemont D, et al. Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychol Med 2014;44: 1171–82.
   PubMed Web of Science ®Google Scholar
• Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F, et al. White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patients. Am J Geriatr Psychiatry 2014;22:157–66.
   Google Scholar
• Kieseppä T, Mäntylä R, Tuulio-Henriksson A, Luoma K, Mantere O, Ketokivi M, et al. White matter hyperintensities and cognitive performance in adult patients with bipolar I, bipolar II, and major depressive disorders. Eur Psychiatry 2014;29:226–32.
   Google Scholar
• Serafini G, Pompili M, Innamorati M, Girardi N, Strusi L, Amore M, et al. The impact of periventricular white matter lesions in patients with bipolar disorder type I. CNS Spectr 2014:1 − 12. PMID: 24411553
   Google Scholar
• O’Brien JT, Wiseman R, Burton EJ, Barber B, Wesnes K, Saxby B, et al. Cognitive associations of subcortical white matter lesions in older people. Ann NY Acad Sci 2002 ;977:436–44.
   Google Scholar
• Wakefield DB, Moscufo N, Guttmann CR, Kuchel GA, Kaplan RF, Pearlson G, et al. White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults. J Am Geriatr Soc 2010;58:275–81.
   PubMed Web of Science ®Google Scholar
• Kaplan RF, Cohen RA, Moscufo N, Guttmann C, Chasman J, Buttaro M, Hall CH, et al. Demographic and biological influences on cognitive reserve. J Clin Exp Neuropsychol 2009;31:868–76.
   PubMed Web of Science ®Google Scholar
• Fink P, Sørensen L, Engberg M, Holm M, Munk-Jørgensen P. Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition . Psychosomatics 1999;40:330–8.
   PubMed Web of Science ®Google Scholar
• Rastas S, Pirttilä T, Mattila K, Verkkoniemi A, Juva K, Niinistö L, et al. Vascular risk factors and dementia in the general population aged > 85 years: Prospective population-based study. Neurobiol Aging 2010;31:1–7.
   PubMedGoogle Scholar
• Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002;58:695–701.
   PubMed Web of Science ®Google Scholar
• Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003;60:878–88.
   PubMed Web of Science ®Google Scholar
• Erkinjuntti T1, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000;59:23–30.
   PubMedGoogle Scholar
• Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–92.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Henderson M, Tannock C. Use of depression rating scales in chronic fatigue syndrome. J Psychosom Res 2005;59:181–4.
   PubMed Web of Science ®Google Scholar
• Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The Health Anxiety Inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002;32:843–53.
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5.
   PubMed Web of Science ®Google Scholar
• Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: Reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 1988;14:61–8.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Messina N, Benattia I, Graepel J, Musgnung J. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. J Clin Psychiatry 2006;67:72–80.
   PubMedGoogle Scholar
• Muller JE, Wentzel I, Koen L, Niehaus DJ, Seedat S, Stein DJ. Escitalopram in the treatment of multisomatoform disorder: A double-blind, placebo-controlled trial. Int Clin Psychopharmacol 2008;23:43–8.
   PubMed Web of Science ®Google Scholar
• Luo YL, Heeramun-Aubeeluck A, Huang X, Ye G, Wu H, Sun L, et al. Factors influencing quality of life in Chinese patients with persistent somatoform pain disorder. Psychol Health Med 2014;19:744–52.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.
   PubMed Web of Science ®Google Scholar
• Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A Frontal Assessment Battery at bedside. Neurology 2000;55:1621–6.
   PubMed Web of Science ®Google Scholar
• Matsuda O, Nakatani N. Manual for Japanese version of the Neurobehavioral Cognitive Status Examination (COGNISTAT). World Plan Tokyo, 2004 (in Japanese).
   Google Scholar
• Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987;149:351–6.
   PubMed Web of Science ®Google Scholar
• Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study. Stroke 2008;39: 1414–20.
   PubMed Web of Science ®Google Scholar
• Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: Three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009;339:b2477
   PubMed Web of Science ®Google Scholar
• Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F, Eikelenboom P, et al. White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. J Clin Psychiatry 2011;72:104–12.
   Google Scholar
• Kim TW, Kim YH, Kim KH, Chang WH. White matter hyperintensities and cognitive dysfunction in patients with infratentorial stroke. Ann Rehabil Med 2014;38:620–7.
   Google Scholar
• Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, et al. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 1998;40:131–7.
   PubMed Web of Science ®Google Scholar
• Meguro K, Hatazawa J, Itoh M, Miyazawa H, Matsuzawa T, Yamadori A. Cerebral blood flow correlated with carotid blood flow in neurologically normal elderly with severe white matter lesions. Eur J Neurol 1998;5:143–9.
   PubMed Web of Science ®Google Scholar
• Sztriha LK, Nemeth D, Sefcsik T, Vecsei L. Carotid stenosis and the cognitive function. J Neurol Sci 2009;283:36–40.
   Google Scholar
• Yochim BP, Mueller AE, Segal DL. Late life anxiety is associated with decreased memory and executive functioning in community dwelling older adults. J Anxiety Disord 2013;27:567–75.
   PubMed Web of Science ®Google Scholar
• Inamura K, Tsuno N, Shinagawa S, Nagata T, Tagai K, Nakayama K. Correlation between cognition and symptomatic severity in patients with late-life somatoform disorders. Aging Ment Health 2015;19:169–74.
   PubMed Web of Science ®Google Scholar
• Hall NM, Kuzminskyte R, Pedersen AD, Ørnbøl E, Fink P. The relationship between cognitive functions, somatization and behavioural coping in patients with multiple functional somatic symptoms. Nord J Psychiatry 2011;65:216–24.
   PubMed Web of Science ®Google Scholar
• Kramer-Ginsberg E, Greenwald BS, Krishnan KR, Christiansen B, Hu J, Ashtari M, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1999;156:438–44.
   PubMed Web of Science ®Google Scholar
• Murata T, Kimura H, Omori M, Kado H, Kosaka H, Iidaka T, et al. MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: A comparison of early-and late-onset cases. Int J Geriatr Psychiatry 2001;16:1129–35.
   PubMed Web of Science ®Google Scholar
• Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Szecenyi J, Löwe B.Depression, anxiety, and somatoform disorders: Vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res 2009;67:189–97.
   PubMed Web of Science ®Google Scholar
• Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005;30:996–1002.
   PubMed Web of Science ®Google Scholar
• Salloway S, Malloy P, Kohn R, Gillard E, Duffy J, Rogg J, et al. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996;46:1567–74.
   PubMed Web of Science ®Google Scholar
• Kashyap H, Kumar JK, Kandavel T, Reddy YC. Neuropsychological correlates of insight in obsessive− compulsive disorder. Acta Psychiatr Scand 2012;126:106–14.
   PubMed Web of Science ®Google Scholar
• Firbank MJ, OBrien JT, Pakrasi S, Pantoni L, Simoni M, Erkinjuntti T, et al. White matter hyperintensities and depression – Preliminary results from the LADIS study. Int J Geriatr Psychiatry 2005;20:674–9.
   PubMedGoogle Scholar
• Koh KB, Sohn SH, Kang JI, Lee YJ, Lee JD. Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Res 2012;202:252–6.
   Google Scholar
• Kahl KG, Schweiger U, Correll C, Müller C, Busch ML, Bauer M, et al. Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Brain Behav 2015;5:e00306.
   PubMed Web of Science ®Google Scholar
• Azad N, Gondal M, Abbas N, Shahid A. Frequency of depression and anxiety in patients attending a diabetes clinic. J Ayub Med Coll Abbottabad 2014;26:323–7.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th edition): DSM-5. Washington, DC: American Psychiatric Press; 2013.
   Google Scholar